CAS 189060-31-9
:6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-[(1S)-2-hydroxy-1-methylethyl]-5-(methoxymethyl)-2-(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-, sodium salt (1:1), (3R,5S,6E)-
Description:
6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-[(1S)-2-hydroxy-1-methylethyl]-5-(methoxymethyl)-2-(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-, sodium salt (1:1), (3R,5S,6E)- is a complex organic compound characterized by its multi-functional groups and specific stereochemistry. This compound features a heptenoic acid backbone, which includes a double bond, indicating its unsaturation. The presence of multiple hydroxyl (-OH) groups suggests it has significant polar characteristics, enhancing its solubility in water and potential reactivity. The fluorophenyl group introduces a fluorine atom, which can influence the compound's electronic properties and biological activity. The pyridine ring contributes to the compound's aromaticity and may play a role in its interaction with biological targets. As a sodium salt, it is likely to be more soluble in aqueous environments, making it suitable for various applications in pharmaceuticals or biochemistry. Overall, this compound's unique structure and functional groups suggest potential utility in medicinal chemistry, particularly in the development of therapeutic agents.
Formula:C26H33FNNaO6
InChI:InChI=1/C26H34FNO6.Na/c1-15(2)25-21(10-9-19(30)11-20(31)12-23(32)33)24(17-5-7-18(27)8-6-17)22(14-34-4)26(28-25)16(3)13-29;/h5-10,15-16,19-20,29-31H,11-14H2,1-4H3,(H,32,33);/q;+1/p-1/b10-9+;/t16-,19-,20-;/m1./s1
InChI key:InChIKey=TUYBKPRGKCUDGR-ZZDRRHRHSA-N
SMILES:C(=C/[C@H](C[C@H](CC(O)=O)O)O)\C=1C(=C(COC)C([C@@H](CO)C)=NC1C(C)C)C2=CC=C(F)C=C2.[Na]
Synonyms:- (3R,5S,6E)- 7-[4-(4-Fluorophenyl)-6-[(1S)-2-hydroxy-1-methylethyl]-5-(methoxymethyl)-2-(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt
- 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(2-hydroxy-1-methylethyl)-5-(methoxymethyl)-2-(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-, monosodium salt, [3R-[3R*,5S*,6E,7(S*)]]-
- 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-[(1S)-2-hydroxy-1-methylethyl]-5-(methoxymethyl)-2-(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-, sodium salt (1:1), (3R,5S,6E)-
- M-23 Metabolite
- M-23 Metabolite, Sodium (E)-7-(3R,5S)-{4-(4-Fluorophenyl)-6-[(S)-(hydroxymethyl)ethyl]-2-isopropyl-5-methoxymethylpyrid-3-yl}-3,5-dihydroxyhept-6-enoate
- Sodium (E)-7-(3R,5S)-(4-(4-Fluorophenyl)-6-[(S)-(Hydroxymethyl)Ethyl]-2-Isopropyl-5-Methoxymethylpyrid-3-Yl)-3,5-Dihydroxyhept-6-Enoate
- HYDROXY CERIVASTATIN, SODIUM SALT
- (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-[(1S)-2-hydroxy-1-Methylethyl]-5-(MethoxyMethyl)-2-(1-Methylethyl)-3-pyridinyl]-3,5-dihydroxy-
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.
6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-[(1S)-2-hydroxy-1-methylethyl]-5-(methoxymethyl)-2-(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-, sodium salt (1:1), (3R,5S,6E)-
CAS:Formula:C26H34FNNaO6Color and Shape:SolidMolecular weight:498.5394Hydroxy Cerivastatin-d3 Sodium Salt
CAS:Controlled ProductApplications A labelled metabolite of Cerivastatin, a competitive inhibitor of HMG-CoA reductase.
References Boberg, M., et al.: Drug Metab. Dispos., 25, 321 (1997),Formula:C26H30D3FNNaO6Color and Shape:NeatMolecular weight:500.55

